SRTSartorius Aktiengesellschaft
170.00EUR+0.12%Mkt Cap: 11.38B EURP/E: 70.13Last update: 2026-05-14

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometr…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)70.13
P/E (Forward)25.14
PEG0.75
P/B4.20
P/S3.20
EV/EBITDA17.97
EV/Revenue4.58
EPS (TTM)2.36
EPS (Forward)6.56
Cash Flow & Leverage
FCF Yield2.75%
FCF Margin8.81%
Operating CF837.00M EUR
CapEx (TTM)441.90M EUR
Net Debt/EBITDA4.12
Net Debt3.73B EUR
Technical
SMA 50172.40 (-1.4%)
SMA 200179.52 (-5.3%)
Beta1.40
S&P 52W Chg24.23%
Avg Vol (30d)2.25K
Avg Vol (10d)1.90K
Technical Indicators
RSI (14)45.6
MACD-1.1638
MACD Signal-0.4282
MACD Hist.-0.7357
BB Upper190.28 EUR
BB Middle175.91 EUR
BB Lower161.54 EUR
BB Width16.34%
ATR (14)6.981 EUR
Vol Ratio (20d)0.53x
52W Range
145.4039% of range208.00
52W High208.00 EUR
52W Low145.40 EUR
Profitability
Gross Margin46.26%
EBITDA Margin25.48%
Profit Margin4.38%
Oper. Margin17.11%
ROE5.72%
ROA1.59%
Revenue Growth1.80%
Earnings Growth
Balance Sheet
Debt/Equity1.58
Current Ratio0.91
Quick Ratio0.45
Book Value/Sh39.20 EUR
Cash/Share8.310 EUR
Dividends
Fwd Div Rate0.7300 EUR
Trail. Div Rate0.7400 EUR
Div. Yield0.44%
5Y Avg Yield0.38%
Payout Ratio31.06%
Ex-Div DateMar 27, 2026
Pay Date
Splits
Last Split4:1
Split DateJun 13, 2016
Ownership
Shares Out.34.24M
Float27.45M
Insiders87.07%
Institutions1.93%
Analyst Consensus
Rating
Target (Mean)251.72 EUR
Target Range68.75 EUR445.00 EUR
# Analysts8
Company
Market Cap11.38B EUR
Enterprise Value16.27B EUR
Revenue (TTM)3.55B EUR
Gross Profit1.64B EUR
Net Income (TTM)154.90M EUR
Revenue/Share51.24 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14.2K
Last Price170.00 EUR
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE0007165631